BACKGROUND: The history of lung transplantation from the first human t
ransplant performed in 1963 to the present is reviewed with particular
focus on the added challenges because of the contaminated bronchus, e
xposure of the graft to airborne organisms, the poor blood supply to t
he bronchus, and the problem of reperfusion pulmonary edema. METHODS:
The technical aspects of single and double sequential lung transplanta
tion are reviewed, as are the current indications for single, double s
equential, and heart/lung transplantation. Criteria for lung transplan
t recipients, in addition to their primary disease are noted, as are a
bsolute and relative contraindications. The standard criteria for dono
r selection are also reviewed. RESULTS: The results of single, double
sequential, and heart-lung transplantation over the past 10 years as r
eported by the International Society for Heart and Lung Transplantatio
n Database are reviewed. In addition, the statistics of the lung and h
eart-lung transplantation program at the University of Colorado Health
Sciences Center are reviewed, including the current immunosuppressive
regimens and early and late monitoring for infection and rejection. T
his experience includes 3 early deaths in the first 53 patients for an
operative mortality of 5.6%, with a 1-year actuarial survival of 90%.
CONCLUSIONS: During the past decade remarkable improvement in the res
ult of single and double sequential lung transplantation have occurred
. As 1-year, actuarial survival is now approaching 90% at some institu
tions. Living related lobar transplantation, new antirejection agents,
chimerism, and xenograft transplantation are areas for continuing and
future investigation. The shortage in donor organ supply continues to
be a very significant factor in limiting human lung transplantation.
(C) 1997 by Excerpta Medica, Inc.